Hydralazine hydrochloride/Hydrochlorothiazide

盐酸肼屈嗪/氢氯噻嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHydralazine hydrochloride/Hydrochlorothiazide
Drug Alias NameApresoline-esidrix
ClassificationSmall molecules
Mechanisms of ActionAmine oxidase, copper containing inhibitorsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsAmine oxidase, copper containingThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Hydralazine hydrochlorideHydrochlorothiazide
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A